Abstract
The TGF-β/Smad and the PI3K/AKT signaling pathways are important regulators of proliferation and apoptosis, and their alterations lead to cancer development. TGF-β acts as a tumor suppressor in premalignant cells, but it is a tumor promoter for cancerous cells. Such dichotomous actions are dictated by different cellular contexts. Here, we have unveiled a PTEN-Smad3 regulatory loop that provides a new insight in the complex cross talk between TGF-β/Smad and PI3K/AKT signaling pathways. We demonstrate that TGF-β triggers apoptosis of wild-type polarized endometrial epithelial cells by a Smad3-dependent activation of PTEN transcription, which results in the inhibition of PI3K/AKT signaling pathway. We show that specific Smad3 knockdown or knockout reduces basal and TGF-β-induced PTEN expression in endometrial cells, resulting in a blockade of TGF-β-induced apoptosis and an enhancement of cell proliferation. Likewise Smad3 deletion, PTEN knockout prevents TGF-β-induced apoptosis and increases cell proliferation by increasing PI3K/AKT/mTOR signaling. In summary, our results demonstrate that Smad3-PTEN signaling axis determine cellular responses to TGF-β.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Massagué J . TGFβ signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616–630.
Massagué J, Seoane J, Wotton D . Smad transcription factors. Genes Dev 2005; 19: 2783–2810.
Heldin C-H, Moustakas A . Role of Smads in TGFβ signaling. Cell Tissue Res 2012; 347: 21–36.
Schmierer B, Hill CS . TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8: 970–982.
Itoh S, ten Dijke P . Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol 2007; 19: 176–184.
Mu Y, Gudey SK, Landström M . Non-Smad signaling pathways. Cell Tissue Res 2012; 347: 11–20.
Zhang YE . Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19: 128–139.
Padua D, Massagué J . Roles of TGFbeta in metastasis. Cell Res 2009; 19: 89–102.
Massagué J . TGFbeta in cancer. Cell 2008; 134: 215–230.
Xu J, Lamouille S, Derynck R . TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156–172.
Heldin C-H, Landström M, Moustakas A . Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21: 166–176.
Zhang L, Zhou F, ten Dijke P . Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. Trends Biochem Sci 2013; 38: 612–620.
Song MS, Salmena L, Pandolfi PP . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283–296.
Conery AR, Cao Y, Thompson EA, Townsend CM, Ko TC, Luo K . Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol 2004; 6: 366–372.
Remy I, Montmarquette A, Michnick SW . PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 2004; 6: 358–365.
Seoane J, Le H-V, Shen L, Anderson SA, Massagué J . Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004; 117: 211–223.
Ding Z, Wu C-J, Chu GC, Xiao Y, Ho D, Zhang J et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 2011; 470: 269–273.
Qin J, Wu S-P, Creighton CJ, Dai F, Xie X, Cheng C-M et al. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature 2013; 493: 236–240.
Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S et al. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene 2014; 33: 1538–1547.
Li Q . Transforming growth factor β signaling in uterine development and function. J Anim Sci Biotechnol 2014; 5: 52.
Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, Matzuk MM . Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet 2011; 7: e1002320.
Gao Y, Li S, Li Q . Uterine epithelial cell proliferation and endometrial hyperplasia: evidence from a mouse model. Mol Hum Reprod 2014; 20: 776–786.
Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E et al. Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene 2013; 32: 403–413.
Hollander MC, Blumenthal GM, Dennis PA . PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 2011; 11: 289–301.
Eritja N, Dolcet X, Matias-Guiu X . Three-dimensional epithelial cultures: a tool to model cancer development and progression. Histol Histopathol 2013; 28: 1245–1256.
Pardali K, Moustakas A . Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007; 1775: 21–62.
Siegel PM, Massagué J . Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807–821.
Ramesh S, Wildey GM, Howe PH . Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim. Cell Cycle 2009; 8: 11–17.
Ramjaun AR, Tomlinson S, Eddaoudi A, Downward J . Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis. Oncogene 2007; 26: 970–981.
Wildey GM, Patil S, Howe PH . Smad3 potentiates transforming growth factor beta (TGFbeta)-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem 2003; 278: 18069–18077.
Ramesh S, Qi X-J, Wildey GM, Robinson J, Molkentin J, Letterio J et al. TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep 2008; 9: 990–997.
Wiener Z, Band AM, Kallio P, Högström J, Hyvönen V, Kaijalainen S et al. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β. Proc Natl Acad Sci USA 2014; 111: E2229–E2236.
Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Rechberger T, Jakowicki JA, Krajewska WM . TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas. Gynecol Oncol 2004; 95: 173–180.
Mhawech-Fauceglia P, Kesterson J, Wang D, Akers S, DuPont NC, Clark K et al. Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer. Histopathology 2011; 59: 63–72.
Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu M-L et al. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 2002; 62: 2778–2790.
Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M et al. High-risk endometrial carcinoma profiling identifies TGF-1 as a key factor in the initiation of tumor invasion. Mol Cancer Ther 2011; 10: 1357–1366.
Bayascas JR . Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways. Cell Cycle 2008; 7: 2978–2982.
Manning BD, Cantley LC . AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261–1274.
Rodon J, Dienstmann R, Serra V, Tabernero J . Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol 2013; 10: 143–153.
Brown KA, Pietenpol JA, Moses HL . A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 2007; 101: 9–33.
Sugiyama Y, Kakoi K, Kimura A, Takada I, Kashiwagi I, Wakabayashi Y et al. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways. Int Immunol 2012; 24: 253–265.
Eritja N, Llobet D, Domingo M, Santacana M, Yeramian A, Matias-Guiu X et al. A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis. Am J Pathol 2010; 176: 2722–2731.
Eritja N, Mirantes C, Llobet D, Masip G, Matias-Guiu X, Dolcet X . ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance. J Cell Sci 2012; 125: 1929–1944.
Baak JP, Kurver PH, Overdiep SH, Delemarre JF, Boon ME, Lindeman J et al. Quantitative, microscopical, computer-aided diagnosis of endometrial hyperplasia or carcinoma in individual patients. Histopathology 1981; 5: 689–695.
Acknowledgements
The study was supported by grants SAF2016-80157-R from Ministerio de Economía y Competitividad, PI13/00263 and PI13/01701 from Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III cofinanciado por Fondo Europeo de Desarrollo Regional (FEDER) (‘Una manera de hacer Europa’), Red Temática de investigación en Cáncer RD12/0036/0013 and Red de Oncología (CIBERONC). Grups consolidats de la Generalitat de Catalunya (2009SGR794), Fundació La Marató de TV3, Grupos estables AECC, Catalunya contra el cáncer and programa de intensificación de la investigación, Instituto Carlos III. We would like to thank Mónica Domingo, Montse Ortrega and Marta Hereu for their technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by S Fulda
Supplementary Information accompanies this paper on Cell Death and Differentiation website
Supplementary information
Rights and permissions
About this article
Cite this article
Eritja, N., Felip, I., Dosil, M. et al. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. Cell Death Differ 24, 1443–1458 (2017). https://doi.org/10.1038/cdd.2017.73
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2017.73
This article is cited by
-
Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503
Cell Death & Disease (2025)
-
Salvianolic acid B inhibits the proliferation and metastasis of A549 lung cancer cells via miR-23a/PTEN/AKT pathway
Scientific Reports (2025)
-
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition
Scientific Reports (2022)
-
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
Nature Communications (2020)
-
Cell death in cancer in the era of precision medicine
Genes & Immunity (2019)
